Category Archives: Uncategorized

Is open source the future of pharma and med tech, or an anomaly?

Technology seems to leap ahead at an astounding pace and is disruptive for many businesses, but is achingly slow for patients who await disease detection and treatments. A recent TED Radio Hour, “Fighting Cancer,” included speakers who addressed their approaches…

FacebookTwitterGoogle+Share

Rehash; FDA device inspections and the Guidant deal

As the summer doldrums draw mercifully to a close, we can look back over a more or less expansive period of time to see where we’ve been in some hope of divining where things might be headed. Or maybe it’s…

FacebookTwitterGoogle+Share

Second bites and second sights: A summer med tech trifecta

Rock and roll radio stations used to tout their two-for-Tuesday and three-for-Thursday lineups, but we at BioWorld MedTech think every day is good for a threefer. Below are three stories of recent vintage to grace the pages of BWT, at…

FacebookTwitterGoogle+Share

Augmented reality check

My first real exposure to what’s commonly called augmented reality was about a year ago when one of my former colleagues introduced me to Pokemon Go. I remember her telling me that you could actually hold up your smartphone or…

FacebookTwitterGoogle+Share

Tech reflects our humanity

When my now middle-aged dog was a puppy, I looked into taking him to basic obedience classes. At one of these sessions, a group of newbie pet owners gathered in a room tucked into the back of a pet store….

FacebookTwitterGoogle+Share

Summer love; med tech ‘court-ship’ heats up

Louis Armstrong’s Summer Song evokes an inviting and mellow season, but a leisurely pace can be a pain in the neck for a med tech writer. The FDA’s device center might not be pumping out guidances of late, but the…

FacebookTwitterGoogle+Share

Philips set to acquire Spectranetics for $2.2B ahead of Stellarex approval

By Omar Ford, Staff Writer Royal Phillips NV is set to acquire Spectranetics Corp. for €1.9 billion ($2.2 billion). The proposed acquisition is the latest in a string of efforts the Amsterdam, the Netherlands-based company has made to strengthen its…

FacebookTwitterGoogle+Share

Glooko closes series C with $35M in financing to improve lives of patients with diabetes

By Katie Pfaff, Staff Writer Diabetes data management company Glooko closed a series C funding round with $35 million in financing, led by Georgian Partners. The Mountain View, Calif., company plans to use the funding to continue growth, including internationally,…

FacebookTwitterGoogle+Share

FDA approves first companion Dx for use with multiple NSCLC drugs

By Stacy Lawrence, Staff Writer The U.S. Food and Drug Administration has approved the Oncomine Dx Target Test from Thermo Fisher Scientific Inc. It is the first test of its kind to screen tumor samples for biomarkers associated with multiple…

FacebookTwitterGoogle+Share

Philips buying Oregon neuro EEG company Electrical Geodesics for €32.9M

By Stacy Lawrence, Staff Writer Royal Philips is slated to purchase Eugene, Ore.-based start up Electrical Geodesics Inc. to add its noninvasive brain activity monitoring and interpretation technology. The deal is expected to complement Philips existing imaging technology and neurological…

FacebookTwitterGoogle+Share

Marketo